全文获取类型
收费全文 | 819篇 |
免费 | 32篇 |
国内免费 | 23篇 |
专业分类
耳鼻咽喉 | 8篇 |
儿科学 | 42篇 |
妇产科学 | 3篇 |
基础医学 | 93篇 |
口腔科学 | 9篇 |
临床医学 | 56篇 |
内科学 | 206篇 |
皮肤病学 | 2篇 |
神经病学 | 11篇 |
特种医学 | 313篇 |
外科学 | 22篇 |
综合类 | 13篇 |
预防医学 | 24篇 |
眼科学 | 18篇 |
药学 | 36篇 |
中国医学 | 1篇 |
肿瘤学 | 17篇 |
出版年
2021年 | 10篇 |
2019年 | 5篇 |
2018年 | 8篇 |
2017年 | 2篇 |
2016年 | 4篇 |
2015年 | 10篇 |
2014年 | 8篇 |
2013年 | 8篇 |
2012年 | 5篇 |
2011年 | 13篇 |
2010年 | 11篇 |
2009年 | 17篇 |
2008年 | 10篇 |
2007年 | 25篇 |
2006年 | 15篇 |
2005年 | 9篇 |
2004年 | 11篇 |
2003年 | 5篇 |
2002年 | 11篇 |
2001年 | 7篇 |
2000年 | 3篇 |
1999年 | 13篇 |
1998年 | 46篇 |
1997年 | 39篇 |
1996年 | 58篇 |
1995年 | 44篇 |
1994年 | 36篇 |
1993年 | 38篇 |
1992年 | 12篇 |
1991年 | 14篇 |
1990年 | 12篇 |
1989年 | 36篇 |
1988年 | 36篇 |
1987年 | 28篇 |
1986年 | 26篇 |
1985年 | 42篇 |
1984年 | 22篇 |
1983年 | 23篇 |
1982年 | 26篇 |
1981年 | 24篇 |
1980年 | 12篇 |
1979年 | 4篇 |
1978年 | 5篇 |
1977年 | 26篇 |
1976年 | 18篇 |
1975年 | 14篇 |
1970年 | 3篇 |
1969年 | 2篇 |
1968年 | 3篇 |
1967年 | 8篇 |
排序方式: 共有874条查询结果,搜索用时 0 毫秒
1.
Jean-yves Gillon Pierre-Alain Vitte Francoise Lemonnier Gabor Kato 《Drug development research》1994,32(1):42-49
Medifoxamine, an antidepressant agent which has an original chemical structure, has been shown through in vitro studies, utilising radioligand binding in tissue homogenates, to bind with moderately high affinity to 5-HT1c and 5-HT2 receptor subtypes and to 5-HT uptake sites (IC50 950, 980, and 1,500 nM, respectively). It has been shown to bind in vivo to rat brain 5-HT2 receptors after acute treatment with high dose (50 mg/kg, i.e., 133.9 μmol/kg). After 14 days continuous treatment with low dose (20 mg/kg, 53.6 μmol/kg), a decrease in the capacity of [3H]-5-HT uptake and a dose-dependent down-regulation of 5-HT2 receptors in rat cerebral cortex were observed. These results indicate that medifoxamine, which has been shown previously to act through dopaminergic systems, interacts also with central serotonergic neurotransmission and particularly with the 5-HT2 receptors, which could contribute to its antidepressant effect. 相似文献
2.
3.
4.
5.
6.
A randomized controlled trial of electromagnetic therapy in the primary care management of venous leg ulceration 总被引:1,自引:1,他引:0
OBJECTIVE: The aim was to establish the potential efficacy, tolerabilityand side-effect profile of electromagnetic therapy as an adjunctto conventional dressings in the treatment of venous leg ulcers. METHOD: A prospective, randomized, double blind controlled clinicaltrial was carried out in a dedicated leg ulcer clinic basedin one urban general practice. Nineteen patients with leg ulcersof confirmed venous aetiology were assessed. The main outcomemeasures were rate and scale of venous leg ulcer healing, changesin patient-reported pain levels, quality of life, degree ofmobility, side effect profile and acceptability to patientsand staff. RESULTS: Sixty-eight per cent of patients attending this dedicated clinicachieved improvements in the size of their ulcer (4, 21%, healedfully) and in reduced pain levels (P < 0.05) during the trial,despite the chronicity of ulcer histories. Patients treatedwith electromagnetic therapy at 800 Hz were found at day 50to have significantly greater healing (P < 0.05) and paincontrol (P < 0.05) than placebo therapy or treatment with600 Hz. All patients reported improved mobility at the end ofthe study. The electromagnetic therapy was well tolerated bypatients, with no differences between groups in reporting adverseevents, and proved acceptable to staff. CONCLUSION: Despite the small numbers in this pilot study, electromagnetictherapy provided significant gains in the healing of venousleg ulcers and reduction in pain. Keywords. Electromagnetic therapy, RCT, leg ulcers, primary care. 相似文献
7.
8.
9.